Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
However, in the pivotal Phase IIb trial, it failed to demonstrate statistically significant weight loss compared to placebo at the primary endpoint, leading the developer (Metabolic Pharmaceuticals Ltd.) to terminate the commercial program
TB-500 is on the WADA prohibited list and would be banned in sanctioned competitions that follow WADA testing protocols, such as the CrossFit Games
Human evidence is still building
The sequence GEPPPGKPADDAGLV and approximate molecular weight near 1419 Da appear in published BPC 157 literature [2]
Microdosing is a drug administration method involving significantly lower doses than are typically used for therapeutic effects
If you are dealing with a tendon, ligament, or joint injury and want the most direct evidence-based option, BPC-157 is the starting point
US$ 25.65
US$ 23.55
US$ 20.75
US$ 26.76
US$ 23.12
US$ 29.20
US$ 26.75
US$ 27.73
